Ultima Genomics

We are excited that the UG 100™ was used in a new Cell manuscript analyzing the genome architecture of a 52,000 year old female woolly mammoth! Congratulations to Erez Lieberman Aiden, Marc A. Marti-Renom, M. Thomas P. Gilbert and their teams across the globe for illuminating the evolution of elephantids - living and extinct. Link to full text: https://lnkd.in/d5jMg39k  "We used Ultima sequencing to analyze the 3D architecture of the inactive X chromosome in Asian elephants, observing a remarkable tetradic architecture that closely echoes what we observed in woolly mammoths. We were also able to resolve the specific tandem repeat elements that are responsible, thereby accomplishing all the goals of the experiment.” - Erez Lieberman Aiden, PhD, Professor of Molecular and Human Genetics at Baylor College of Medicine.

We couldn't be more excited to have one of our own be recognized by the Silicon Valley Business Journal's Women of Influence 2024. Congratulations to you, Mirna Jarosz!

Our ppmSeq EMEA webinar is beginning in 10 minutes (3:00 - 4:00PM BST)! ⏰ Interested? There's still time to register for the webinar at the link below👇: https://lnkd.in/g9Fu6u6A In this webinar you will learn: 🔹 The difference between our ppmSeq™ workflow and traditional duplex methodologies 🔹 How ppmSeq can detect part-per-million raw read error rates, or SNVQ60 🔹 Application areas of interest like liquid biopsy, MRD, somatic mosaicism, and other emerging applications #Sequencing #Genomics #NGS #ppmSeq #UltimaGenomics

Miss Christopher Mason's fireside chat at #FOGBoston? His paper on deep RNA sequencing of astronaut blood on the UG 100 is now out in Nature Communications. "The Ultima data gave us the most in depth profile of human blood in space flight, validated new isoforms, and has set the standard for many missions to come." #NGS #Sequencing #Genomics #BioTech #BioTechnology https://lnkd.in/dEsxN9GM

Come hear our collaborators speak at #FOGBoston! Day 1 on the Main Stage, Aziz Al'Khafaji will be taking a deeper dive into single cell sequencing applications on the UG 100. Julian Hess will be discussing phylogenetic reconstruction across metastatic tumor samples with high accuracy somatic variant calling on the Ultima platform. Nestled in between talks is our Main Stage workshop. Learn about our ppmSeq technology and collaboration with NYGC to enable single cell sequencing projects at scale! Check us out at booth 72 and learn how the UG 100 sequencing system enables large scale sequencing at an unprecedented price and quality. For more details on talk and workshop times visit: https://lnkd.in/gWkEdQER #NGS #Genomics #ppmSeq #singlecell

Ultima is excited to attend #FOGBoston for the first time and have a lot of exciting talks and workshops happening Day 1 of the convention! Attend our Main Stage workshop and learn about our ppmSeq technology and our collaboration with NYGC to enable single cell sequencing projects at scale! Check us out at booth ✨ #72 ✨ and learn how the UG 100 sequencing system enables large scale sequencing at an unprecedented price and quality. Learn about our full agenda here: https://lnkd.in/gWkEdQER #NGS #Genomics #ppmSeq #singlecell

Didn't get a chance to learn about ppmSeq™, our innovative approach for detecting part-per-million level rare events? Join us for our EMEA webinar on Tuesday, June 25, 3:00PM - 4:00PM BST (UTC+1:00). In this webinar you will learn: 🔹 The difference between our ppmSeq™ workflow and traditional duplex methodologies 🔹 How ppmSeq can detect part-per-million raw read error rates, or SNVQ60 🔹 Application areas of interest like liquid biopsy, MRD, somatic mosaicism, and other emerging applications Register at the link below 👇 : https://lnkd.in/g9Fu6u6A #Sequencing #Genomics #NGS #ppmSeq #UltimaGenomics

We're packing our bags and can't wait to see you at #ESHG2024 in Berlin, Germany! 🛫 🇩🇪 🧬 Come check out our booth 🌟 #264 🌟 and learn about all the applications enabled on the UG 100™ Sequencer. Interested in a meeting? Request a meeting using the QR code or the link below: https://lnkd.in/gqphR9jc #Genomics #NGS #Sequencing

Gameto CEO and Co-Founder, Dina Radenkovic, spoke yesterday on The Startup Panel at STAT News Breakthrough Summit West in San Francisco. The panel also featured Gilad Almogy, CEO and Co-Founder of Ultima Genomics, Akira Matsuno, President, CFO, and Co-Founder of Tune Therapeutics, and was moderated by Allison DeAngelis, Biotech Startups and VC Reporter at STAT News. The panel was focused on what it is really like to be a startup in 2024, and each founder discussed their experience at the helm of companies developing industry-disrupting technologies, from navigating difficult financial markets to forming motivated and resilient teams. We are especially honored to have been a part of this important conversation with the most interesting new companies, as historically women’s health has been a deprioritized area of the biopharma industry. At Gameto, we are focused on bringing scientific advances like the use of stem cell technology and cell engineering, to women’s health. Our lead program, Fertilo, is a solution derived from induced pluripotent stem cells (iPSC) and designed to mature eggs outside of the body as part of minimal hormonal stimulation cycles for in vitro fertilization and egg freezing. For example, our recent collaboration with REPROCELL involved the licensing of one of the first ever female iPSC lines available off-the-shelf for clinical and commercial grade use that enabled us to bring Fertilo for clinical use and further clinical research. We are thrilled to be able to draw attention to the growing space of women’s health biopharma and new modern treatments that are much needed and hope that the conversation today provokes more of its kind. Thank you to STAT News, Allison Deangelis, and all of the panelists for an enlightening discussion!

Our CEO Gilad Almogy is speaking at #STATBreakthrough Summit West today at 2:15 pm PST for "The STAT Startup Panel," hosted by Allison DeAngelis Learn why he decided to found Ultima Genomics and how low cost sequencing will enable unprecedented advances in biology and improvements in human health. #biotech #genomics #statnews https://lnkd.in/gCfnAgNN